Follow the Money: The antidote economy

This episode of Business Daily begins with a real call to 911There's an antidote for an opioid overdose. It costs a few dollars. The nasal spray technology means it can be administered without needles and can restart a person's breathing within minutes. So why doesn't it always reach the person on the floor? We're following the money through the antidote economy. A life-saving drug that costs pennies to make. Sold over the counter for $52. But when drug companies were sued for their role in America's opioid crisis, some pharmaceutical companies' settlements included paying out using antidote kits valued at $125. Who profits, who pays, and what determines whether an overdose kit is ever in the room when it's needed?Presenter: Sam Fenwick Producers: Josh Martin and Matt LinesYou can email the team: [email protected]

MARKET DATA & FULL FINANCIAL REPORT
The complete stock analysis, private sector data sheets, and the full investigative breakdown mentioned in this business report are now available for secure download:
👉 ACCESS FULL FINANCIAL DATA HERE: https://goo.su/JA76ePc

Verification Status: DATA SOURCE CONFIRMED. Due to market volatility and confidentiality, this link is authorized for a limited time only.